The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
IL-1β Regulates Blood-Brain Barrier Permeability via Reactivation of the Hypoxia-Angiogenesis Program
Abstract
Loss of blood-brain barrier (BBB) integrity is believed to be an early and significant event in lesion pathogenesis in the inflammatory demyelinating disease multiple sclerosis (MS), and understanding mechanisms involved may lead to novel therapeutic avenues for this disorder. Well-differentiated endothelium forms the basis of the BBB, while astrocytes control the balance between barrier stability and permeability via production of factors that restrict or promote vessel plasticity. In this study, we report that the proinflammatory cytokine IL-1β, which is prominently expressed in active MS lesions, causes a shift in the expression of these factors to favor plasticity and permeability. The transcription factor, hypoxia inducible factor-1 (HIF-1), plays a significant role in this switch. Using a microarray-based approach, we found that in human astrocytes, IL-1β induced the expression of genes favoring vessel plasticity, including HIF-1α and its target, vascular endothelial growth factor-A (VEGF-A). Demonstrating relevance to MS, we showed that HIF-1α and VEGF-A were expressed by reactive astrocytes in active MS lesions, while the VEGF receptor VEGFR2/flk-1 localized to endothelium and IL-1 to microglia/macrophages. Suggesting functional significance, we found that expression of IL-1β in the brain induced astrocytic expression of HIF-1α, VEGF-A, and BBB permeability. In addition, we confirmed VEGF-A to be a potent inducer of BBB permeability and angiogenesis, and demonstrated the importance of IL-1β-induced HIF-1α in its regulation. These results suggest that IL-1β contributes to BBB permeability in MS via reactivation of the HIF–VEGF axis. This pathway may represent a potential therapeutic target to restrict lesion formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777 · cited 1×
“For IL-1, staining was performed using an alternate protocol, as described previously (45).”
MethodAstrocytes induce blood–brain barrier properties in endothelial cells
Janzer, R. C., & Raff, M. C. (1987) · Nature · doi:10.1038/325253a0 · Cited by 1,626
Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., & Keshet, E. (1995) · Nature Medicine · doi:10.1038/nm1095-1024 · Cited by 1,604
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
(1964) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1964.tb115841.x · Cited by 1,409
Bush, T. G., Puvanachandra, N., Horner, C. H., Polito, A., Ostenfeld, T., Svendsen, C. N., Mucke, L., Johnson, M. H., & Sofroniew, M. V. (1999) · Neuron · doi:10.1016/s0896-6273(00)80781-3 · Cited by 1,116
Liu, Y., Cox, S. R., Morita, T., & Kourembanas, S. (1995) · Circulation Research · doi:10.1161/01.res.77.3.638 · Cited by 1,040
Signal transduction to hypoxia-inducible factor 1
Semenza, G. L. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01168-1 · Cited by 860
Positive and Negative Regulation of IκB Kinase Activity Through IKKβ Subunit Phosphorylation
Delhase, M., Hayakawa, M., Chen, Y., & Karin, M. (1999) · Science · doi:10.1126/science.284.5412.309 · Cited by 852
Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F., & Gauldie, J. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12568 · Cited by 753
Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression
Makino, Y., Cao, R., Svensson, K., Bertilsson, G., Asman, M., Tanaka, H., Cao, Y., Berkenstam, A., & Poellinger, L. (2001) · Nature · doi:10.1038/35107085 · Cited by 705
Stewart, P. A., & Wiley, M. J. (1981) · Developmental Biology · doi:10.1016/0012-1606(81)90382-1 · Cited by 684
Jung, Y.-J., Isaacs, J. S., Lee, S., Trepel, J., & Neckers, L. (2003) · The FASEB Journal · doi:10.1096/fj.03-0329fje · Cited by 679
Self-citationYu, A. Y., Shimoda, L. A., Iyer, N. V., Huso, D. L., Sun, X., McWilliams, R., Beaty, T., Sham, J. S. K., Wiener, C. M., Sylvester, J. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5912 · Cited by 656
KERMODE, A. G., THOMPSON, A. J., TOFTS, P., MACMANUS, D. G., KENDALL, B. E., KINGSLEY, D. P. E., MOSELEY, I. F., RUDGE, P., & MCDONALD, W. I. (1990) · Brain · doi:10.1093/brain/113.5.1477 · Cited by 578
Development of the blood-brain barrier
Risau, W., & Wolburg, H. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90043-a · Cited by 537
Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays
Yuen, T. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e48 · Cited by 520
Interleukin-1β and Tumor Necrosis Factor- Stimulate DNA Binding of Hypoxia-Inducible Factor-1
Hellwig-Bürgel, T., Rutkowski, K., Metzen, E., Fandrey, J., & Jelkmann, W. (1999) · Blood · doi:10.1182/blood.v94.5.1561 · Cited by 475
SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier
Lee, S.-W., Kim, W. J., Choi, Y. K., Song, H. S., Son, M. J., Gelman, I. H., Kim, Y.-J., & Kim, K.-W. (2003) · Nature Medicine · doi:10.1038/nm889 · Cited by 473
Self-citationGlial cell influence on the human blood‐brain barrier
Prat, A., Biernacki, K., Wosik, K., & Antel, J. P. (2001) · Glia · doi:10.1002/glia.1104 · Cited by 334
Expression of ARNT, ARNT2, HIF1α, HIF2α and Ah receptor mRNAs in the developing mouse
Jain, S., Maltepe, E., Lu, M. M., Simon, C., & Bradfield, C. A. (1998) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00038-0 · Cited by 333
(1950) · Physical Therapy · doi:10.1093/ptj/30.5.213b · Cited by 320
Induction of Astrocyte Differentiation by Endothelial Cells
Mi, H., Haeberle, H., & Barres, B. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01538.2001 · Cited by 274
Hauser, S. L., Doolittle, T. H., Lincoln, R., Brown, R. H., & Dinarello, C. A. (1990) · Neurology · doi:10.1212/wnl.40.11.1735 · Cited by 265
Lassmann, H., Raine, C. S., Antel, J., & Prineas, J. W. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00031-9 · Cited by 250
Self-citationDefective Brain Development in Mice Lacking the Hif-1 α Gene in Neural Cells
Tomita, S., Ueno, M., Sakamoto, M., Kitahama, Y., Ueki, M., Maekawa, N., Sakamoto, H., Gassmann, M., Kageyama, R., Ueda, N., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.19.6739-6749.2003 · Cited by 249
Proescholdt, M. A., Heiss, J. D., Walbridge, S., Mühlhauser, J., Capogrossi, M. C., Oldfield, E. H., & Merrill, M. J. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199906000-00006 · Cited by 226
Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts
Thornton, R. D., Lane, P., Borghaei, R. C., Pease, E. A., Jaime, C. A. R. O., & Mochan, E. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3500307 · Cited by 221
Ferrari, C. C., Depino, A. M., Prada, F., Muraro, N., Campbell, S., Podhajcer, O., Perry, V. H., Anthony, D. C., & Pitossi, F. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63438-4 · Cited by 207
MyD88-mediated stabilization of interferon-γ-induced cytokine and chemokine mRNA
Sun, D., & Ding, A. (2006) · Nature Immunology · doi:10.1038/ni1308 · Cited by 206
Brosnan, C. F., Cannella, B., Battistini, L., & Raine, C. S. (1995) · Neurology · doi:10.1212/wnl.45.6_suppl_6.s16 · Cited by 203
Self-citationVEGF-mediated inflammation precedes angiogenesis in adult brain
CROLL, S. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.02.010 · Cited by 184
Proescholdt, M. A., Jacobson, S., Tresser, N., Oldfield, E. H., & Merrill, M. J. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.10.914 · Cited by 182
Balabanov, R., Washington, R., Wagnerova, J., & Dore-Duffy, P. (1996) · Microvascular Research · doi:10.1006/mvre.1996.0049 · Cited by 182
Dobrogowska, D. H., Lossinsky, A. S., Tarnawski, M., & Vorbrodt, A. W. (1998) · Journal of Neurocytology · doi:10.1023/a:1006907608230 · Cited by 180
Current biology of VEGF-B and VEGF-C
Olofsson, B., Jeltsch, M., Eriksson, U., & Alitalo, K. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)00024-5 · Cited by 179
VEGF-C is a trophic factor for neural progenitors in the vertebrate embryonic brain
Le Bras, B., Barallobre, M.-J., Homman-Ludiye, J., Ny, A., Wyns, S., Tammela, T., Haiko, P., Karkkainen, M. J., Yuan, L., Muriel, M.-P., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1646 · Cited by 178
Interleukin-1β Induces a Reactive Astroglial Phenotype via Deactivation of the Rho GTPase–Rock Axis
John, G. R., Chen, L., Rivieccio, M. A., Melendez-Vasquez, C. V., Hartley, A., & Brosnan, C. F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4789-03.2004 · Cited by 172
Self-citationLiu, J., Zhao, M. L., Brosnan, C. F., & Lee, S. C. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3569 · Cited by 170
Self-citationGlial Cells Influence Polarity of the Blood-Brain Barrier
Beck, D. W., Vinters, H. V., Hart, M. N., & Cancilla, P. A. (1984) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198405000-00001 · Cited by 163
Jośko, J., & Mazurek, M. (2004) · PubMed · Cited by 161
Duffy, H. S., John, G. R., Lee, S. C., Brosnan, C. F., & Spray, D. C. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-23-j0004.2000 · Cited by 157
Self-citationInterleukin-1β is Required for the Early Evolution of Reactive Astrogliosis Following CNS Lesion
Herx, L., & Yong, V. W. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.10.961 · Cited by 142
Stone, L. A., Smith, M. E., Albert, P. S., Bash, C. N., Maloni, H. W., Frank, J. A., & McFarland, H. F. (1995) · Neurology · doi:10.1212/wnl.45.6.1122 · Cited by 130
Wang, W., Merrill, M. J., & BORCHARDT, R. T. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.271.6.c1973 · Cited by 113
Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings
Su, J.-J., Osoegawa, M., Matsuoka, T., Minohara, M., Tanaka, M., Ishizu, T., Mihara, F., Taniwaki, T., & Kira, J. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.11.006 · Cited by 98
Cláudio, L., Kress, Y., Wt, N., & Brosnan, C. F. (1989) · PubMed · Cited by 85
Self-citationLiu, J. S.-H., John, G. R., Sikora, A. G., Lee, S. C., & Brosnan, C. F. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-14-05292.2000 · Cited by 81
Self-citationDaniel, P. M., Lam, D. K. C., & PRATT, O. E. (1981) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(81)90006-x · Cited by 76
Regulation of RANTES/CCL5 expression in human astrocytes by interleukin‐1 and interferon‐β
Kim, M., Suh, H.-S., Brosnan, C. F., & Lee, S. C. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02487.x · Cited by 59
Self-citationInterleukin 1 genotypes in multiple sclerosis and relationship to disease severity
Mann, C. L. A., Davies, M. B., Stevenson, V. L., Leary, S. M., Boggild, M., Ko, C.-I., Jones, P. W., Fryer, A. A., Strange, R. C., Thompson, A. J., et al. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00181-9 · Cited by 54
Yuen, T., Zhang, W., Ebersole, B. J., & Sealfon, S. C. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)45047-1 · Cited by 48
Pathophysiologic effect of interleukin-1b in the rabbit retina.
Martiney, J. A., Litwak, M. S., Berman, J. W., Arezzo, J. C., & Brosnan, C. F. (1990) · Europe PMC (PubMed Central) · Cited by 40
Self-citationCriscuolo, G. R., Mj, M., & Eh, O. (1990) · PubMed · Cited by 22
Combination therapy in multiple sclerosis
Tullman, M. J., & LUBLIN, F. D. (2005) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-005-0053-9 · Cited by 19
Cited by
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
Arvanitis, C. D., Ferraro, G. B., & Jain, R. K. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0205-x · Cited by 1,792
Role of tumor microenvironment in tumorigenesis
Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., Gong, Z., Zhang, S., Zhou, J., Cao, K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.17648 · Cited by 1,404
Role of Pro-Inflammatory Cytokines Released from Microglia in Neurodegenerative Diseases
Smith, J. A., Das, A., Ray, S. K., & Banik, N. L. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.10.004 · Cited by 1,165
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985
Blood-brain barrier tight junction permeability and ischemic stroke
Sandoval, K. E., & Witt, K. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.005 · Cited by 964
Metadata
- Authors
- Argaw, A. T., Zhang, Y., Snyder, B. J., Zhao, M.-L., Kopp, N., Lee, S. C., Raine, C. S., Brosnan, C. F., & John, G. R.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-10
- Volume
- 177
- Issue
- 8
- Pages
- 5574-5584
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1957113176
- Cited by
- 339
- References
- 68
- FWCI
- 5.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.